MARKSANS
MARKSANS PHARMA LIMITED

257.35 -1.14 (-0.44%)

Don't consider buying MARKSANS now, it is risky at the moment

02 Jul, 20255 min read

MARKSANS underperformed today. On a longer term basis, investors in MARKSANS PHARMA LIMITED made +0.03% per day. Wednesday's performance of -0.44% was a significant underperformance compared to it's daily average.

Want to improve your Portfolio's performance?
Spotalpha's Portfolio optimizer is all you need to improve your returns and reduce your risk.
Optimize Portfolio NOW
Read analysis
Following
Symbol Price {{retType}} | Tr.
{{detail.symbol}} {{detail.close}} {{detail.priceChange}}  {{detail.pctChange}}%  {{detail.name}} {{detail.trend}}